The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
Morning Overview on MSN
Frozen mammoth discovery shatters what scientists knew about ancient RNA
When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...
Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...
Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...
A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...
Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback